BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 19706159)

  • 1. Characterization of a novel Nav1.5 channel mutation, A551T, associated with Brugada syndrome.
    Chiang KC; Lai LP; Shieh RC
    J Biomed Sci; 2009 Aug; 16(1):76. PubMed ID: 19706159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SCN5A(K817E), a novel Brugada syndrome-associated mutation that alters the activation gating of NaV1.5 channel.
    Kinoshita K; Takahashi H; Hata Y; Nishide K; Kato M; Fujita H; Yoshida S; Murai K; Mizumaki K; Nishida K; Yamaguchi Y; Kano M; Tabata T; Nishida N
    Heart Rhythm; 2016 May; 13(5):1113-1120. PubMed ID: 26776555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distinct functional defect of three novel Brugada syndrome related cardiac sodium channel mutations.
    Hsueh CH; Chen WP; Lin JL; Tsai CT; Liu YB; Juang JM; Tsao HM; Su MJ; Lai LP
    J Biomed Sci; 2009 Feb; 16(1):23. PubMed ID: 19272188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome.
    Wang L; Meng X; Yuchi Z; Zhao Z; Xu D; Fedida D; Wang Z; Huang C
    Cell Physiol Biochem; 2015; 36(6):2250-62. PubMed ID: 26279430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophysiological characteristics of a SCN5A voltage sensors mutation R1629Q associated with Brugada syndrome.
    Zeng Z; Zhou J; Hou Y; Liang X; Zhang Z; Xu X; Xie Q; Li W; Huang Z
    PLoS One; 2013; 8(10):e78382. PubMed ID: 24167619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lidocaine-induced Brugada syndrome phenotype linked to a novel double mutation in the cardiac sodium channel.
    Barajas-Martínez HM; Hu D; Cordeiro JM; Wu Y; Kovacs RJ; Meltser H; Kui H; Elena B; Brugada R; Antzelevitch C; Dumaine R
    Circ Res; 2008 Aug; 103(4):396-404. PubMed ID: 18599870
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced fast-inactivated state stability of cardiac sodium channels by a novel voltage sensor SCN5A mutation, R1632C, as a cause of atypical Brugada syndrome.
    Nakajima T; Kaneko Y; Saito A; Ota M; Iijima T; Kurabayashi M
    Heart Rhythm; 2015 Nov; 12(11):2296-304. PubMed ID: 26031372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel mutation L619F in the cardiac Na+ channel SCN5A associated with long-QT syndrome (LQT3): a role for the I-II linker in inactivation gating.
    Wehrens XH; Rossenbacker T; Jongbloed RJ; Gewillig M; Heidbüchel H; Doevendans PA; Vos MA; Wellens HJ; Kass RS
    Hum Mutat; 2003 May; 21(5):552. PubMed ID: 12673799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p.D1690N sodium voltage-gated channel α subunit 5 mutation reduced sodium current density and is associated with Brugada syndrome.
    Zeng Z; Xie Q; Huang Y; Zhao Y; Li W; Huang Z
    Mol Med Rep; 2016 Jun; 13(6):5216-22. PubMed ID: 27108952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel missense mutation, I890T, in the pore region of cardiac sodium channel causes Brugada syndrome.
    Tarradas A; Selga E; Beltran-Alvarez P; Pérez-Serra A; Riuró H; Picó F; Iglesias A; Campuzano O; Castro-Urda V; Fernández-Lozano I; Pérez GJ; Scornik FS; Brugada R
    PLoS One; 2013; 8(1):e53220. PubMed ID: 23308164
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gating-dependent mechanisms for flecainide action in SCN5A-linked arrhythmia syndromes.
    Viswanathan PC; Bezzina CR; George AL; Roden DM; Wilde AA; Balser JR
    Circulation; 2001 Sep; 104(10):1200-5. PubMed ID: 11535580
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A heterozygous deletion mutation in the cardiac sodium channel gene SCN5A with loss- and gain-of-function characteristics manifests as isolated conduction disease, without signs of Brugada or long QT syndrome.
    Zumhagen S; Veldkamp MW; Stallmeyer B; Baartscheer A; Eckardt L; Paul M; Remme CA; Bhuiyan ZA; Bezzina CR; Schulze-Bahr E
    PLoS One; 2013; 8(6):e67963. PubMed ID: 23840796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A sodium channel pore mutation causing Brugada syndrome.
    Pfahnl AE; Viswanathan PC; Weiss R; Shang LL; Sanyal S; Shusterman V; Kornblit C; London B; Dudley SC
    Heart Rhythm; 2007 Jan; 4(1):46-53. PubMed ID: 17198989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhanced Na(+) channel intermediate inactivation in Brugada syndrome.
    Wang DW; Makita N; Kitabatake A; Balser JR; George AL
    Circ Res; 2000 Oct; 87(8):E37-43. PubMed ID: 11029409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigations of the Navβ1b sodium channel subunit in human ventricle; functional characterization of the H162P Brugada syndrome mutant.
    Yuan L; Koivumäki JT; Liang B; Lorentzen LG; Tang C; Andersen MN; Svendsen JH; Tfelt-Hansen J; Maleckar M; Schmitt N; Olesen MS; Jespersen T
    Am J Physiol Heart Circ Physiol; 2014 Apr; 306(8):H1204-12. PubMed ID: 24561865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of influence of sex hormones on Brugada syndrome-associated mutant Nav1.5 sodium channel.
    Yang G; Liu J; Wang Y; Du Y; Ma A; Wang T
    J Electrocardiol; 2019; 52():82-87. PubMed ID: 30476647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel SCN5A mutation V1340I in Brugada syndrome augmenting arrhythmias during febrile illness.
    Samani K; Wu G; Ai T; Shuraih M; Mathuria NS; Li Z; Sohma Y; Purevjav E; Xi Y; Towbin JA; Cheng J; Vatta M
    Heart Rhythm; 2009 Sep; 6(9):1318-26. PubMed ID: 19648062
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biophysical phenotypes of SCN5A mutations causing long QT and Brugada syndromes.
    Baroudi G; Chahine M
    FEBS Lett; 2000 Dec; 487(2):224-8. PubMed ID: 11150514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p.D1690N Nav1.5 rescues p.G1748D mutation gating defects in a compound heterozygous Brugada syndrome patient.
    Núñez L; Barana A; Amorós I; de la Fuente MG; Dolz-Gaitón P; Gómez R; Rodríguez-García I; Mosquera I; Monserrat L; Delpón E; Caballero R; Castro-Beiras A; Tamargo J
    Heart Rhythm; 2013 Feb; 10(2):264-72. PubMed ID: 23085483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a novel SCN5A mutation associated with Brugada syndrome reveals involvement of DIIIS4-S5 linker in slow inactivation.
    Casini S; Tan HL; Bhuiyan ZA; Bezzina CR; Barnett P; Cerbai E; Mugelli A; Wilde AA; Veldkamp MW
    Cardiovasc Res; 2007 Dec; 76(3):418-29. PubMed ID: 17854786
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.